Needle Safety Systems Market Global Report 2026

The needle safety systems market size has grown strongly in recent years. It will grow from $2.43 billion in 2025 to $2.65 billion in 2026 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to rising awareness of healthcare worker safety standards, increasing incidence of needlestick injuries in clinical settings, introduction of early safety engineered syringe designs, growth in hospital infection control protocols, regulatory push for safer medical injection practices.

The needle safety systems market size is expected to see strong growth in the next few years. It will grow to $3.75 billion in 2030 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to expansion of global vaccination and immunization programs, increasing regulatory mandates for healthcare worker protection, rising adoption of automated safety medical devices in hospitals, growth in home healthcare and self-injection therapies, technological advancement in low-cost safety needle mechanisms. Major trends in the forecast period include increasing adoption of retractable needle technologies for reducing needlestick injuries, rising integration of automatic safety locking mechanisms in syringes and infusion devices, development of cost-effective passive safety needle systems for mass immunization programs, growing preference for single-use safety engineered injection devices in hospitals, expansion of safety compliance-driven medical device procurement in healthcare institutions.

The increasing immunization and vaccination programs worldwide are expected to drive the growth of the needle safety systems market going forward. Immunization and vaccination programs refer to organized public health initiatives aimed at preventing infectious diseases through the administration of vaccines to populations. The rise in immunization and vaccination programs is primarily driven by government-led initiatives to expand disease prevention coverage, particularly through national immunization campaigns. Needle safety systems improve immunization and vaccination programs by reducing needlestick injuries and cross-contamination, ensuring safer administration for healthcare workers and patients while enhancing compliance and supporting large-scale vaccination through reliable, user-friendly designs that reduce infection risks and medical waste. For instance, in July 2024, according to the United Nations Children's Fund (UNICEF), a US-based international organization providing humanitarian and developmental aid to children worldwide, the global proportion of adolescent girls receiving at least one dose of the HPV vaccine increased from 20% in 2022 to 27% in 2023, marking a 7-percentage-point rise. Therefore, increasing immunization and vaccination programs worldwide is driving the growth of the needle safety systems market.

Leading operating in the needle safety systems market are increasingly focusing on adopting advanced passive safety-engineered technologies, such as retractable needle mechanisms and shielded syringe designs, to reduce needlestick injuries, enhance healthcare worker protection, and improve compliance with occupational safety standards across hospitals, clinics, and surgical settings. Retractable needle mechanisms and shielded syringe designs refer to safety-engineered features that automatically withdraw or cover the needle after use to prevent accidental needlestick injuries. For example, in January 2026, Terumo Medical Corporation, a US-based medical technology company, introduced the SurTract Safety Syringe in the United States, incorporating Roncadelle Operations’ SafeR passive safety technology. This innovation is designed to automatically activate a safety mechanism after injection, helping to reduce accidental needlestick injuries and improve user safety without requiring additional steps from healthcare professionals. Such advancements support the growing adoption of passive needle safety systems, enabling improved clinical workflow efficiency, enhanced infection control practices, and stronger demand across hospitals, emergency care units, and outpatient care settings.

In February 2025, Unither Pharmaceuticals, a France-based company specializing in innovative sterile single-dose injection systems using Blow-Fill-Seal (BFS) technology, including the Euroject platform, entered into a strategic collaboration with Needle Concept. Through this partnership, both companies aim to develop advanced next-generation needles compatible with the Euroject system to enhance safety, sterility, and efficiency in single-dose injectable drug delivery, while reducing handling risks and improving usability in large-scale medical applications. Needle Concept is a France-based medical device manufacturer focused on designing and producing high-precision needles and safety injection systems.

Major companies operating in the needle safety systems market are Becton Dickinson and Company, Shandong Weigao Group Medical Polymer Company Limited, B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, Kindly Medical Group, Vygon S. A., Sarstedt AG & Co. KG, Improve Medical Instruments Co. Ltd., Lifelong Meditech Private Limited, SOL-Millennium Medical Group, Numedico Technologies Pty Ltd, Sharps Technology Inc., DMC Medical Limited, Retractable Technologies Inc., Jiangsu Jichun Medical Devices Co. Ltd., Hindustan Syringes & Medical Devices Limited, West Pharmaceutical Services Inc., Revolutions Medical Corporation, AdvaCare Pharma, Gerresheimer AG.

North America was the largest region in the needle safety systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the needle safety systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the needle safety systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The needle safety systems market consists of sales of needle shield devices, auto-disable syringes, and safety lancets. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.